title: Impact of serum insulin-like growth factor-1 on early prognosis in acute myocardial infarction.
abstract: OBJECTIVE
  Previous research revealed that a low concentration of serum insulin-like growth factor-1 (IGF-1) is associated with risks of myocardial infarction and heart failure. We hypothesized that the serum IGF-1 level affects clinical outcome in acute myocardial infarction (AMI). We examined the impact of serum IGF-1 in acute phase of AMI on 90-day mortality.
  
  
  METHODS
  In 54 patients with AMI, we measured serum total IGF-1 concentration on admission, in acute phase (1.9+/-0.5 days) and in chronic phase (28.5+/-6.7 days). We measured plasma brain natriuretic peptide (BNP), glucose and insulin in acute phase, and calculated insulin resistance (HOMA-R).
  
  
  RESULTS
  Serum IGF-1 was 135.6+/-51.1 ng/ml on admission and significantly decreased to 105.5+/-42.2 ng/ml in acute phase, and then returned to baseline of 136.7+/-52.2 ng/ml in chronic phase. Five patients died of cardiac reasons within 90 days, all of whom had lower IGF-1 on admission and lower IGF-1 in acute phase than their median of 54 patients. Patients with the concentration of IGF-1 on admission below the median (<131 ng/ml) had significantly lower survival rate than those at or above the median (log-rank test p=0.0169). However, patients with BNP concentration at or above the median (> or =227 pg/ml) had a similar survival rate to those below the median (log-rank test p=0.6797). Multivariate analysis clarified that IGF-1 on admission was the sole independent predictor of 90-day mortality (p=0.007, risk ratio=0.927).
  
  
  CONCLUSIONS
  A low concentration of serum IGF-1 on admission was associated with a poor early prognosis of acute myocardial infarction.
authors.affiliation: Division of Cardiology, Health Insurance Naruto Hospital, Naruto.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Yamaguchi
authors.forename: Kazuo
authors.initials: K
authors.lastname: Komamura
authors.forename: Masahito
authors.initials: M
authors.lastname: Choraku
authors.forename: Akira
authors.initials: A
authors.lastname: Hirono
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Takamori
authors.forename: Katsuya
authors.initials: K
authors.lastname: Tamura
authors.forename: Masashi
authors.initials: M
authors.lastname: Akaike
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Azuma
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood*; D011379:Prognosis; D016016:Proportional Hazards Models
chemical_list: D015415:Biomarkers; D007334:Insulin-Like Growth Factor I